A151 FECAL CALPROTECTIN RETURN RATE IN IBD PATIENTS ON INFLIXIMAB
نویسندگان
چکیده
منابع مشابه
Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy
BACKGROUND Infliximab is an effective therapy for inflammatory bowel disease (IBD). However, more than 50% of patients lose response. Empiric dose intensification is not effective for all patients because not all patients have objective disease activity or subtherapeutic drug level. The aim was to determine how an objective marker of disease activity or therapeutic drug monitoring affects clini...
متن کاملFecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran
Background: Inflammatory bowel disease (IBD) is a chronic disease with a relapsing course of inflammation in the digestive system. Endoscopy and histopathology are the golden standard methods for detection and assessment of IBD. A distinct increase of fecal calprotectin level can be a useful marker for the diagnosis of IBD. The aim of this study was to evaluate the fecal calprotectin level in p...
متن کاملFecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran
Background Inflammatory bowel disease (IBD) is a chronic disease with a relapsing course of inflammation in the digestive system. Endoscopy and histopathology are the golden standard methods for detection and assessment of IBD. A distinct increase of fecal calprotectin level can be a useful marker for the diagnosis of IBD. The aim of this study was to evaluate the fecal calprotectin level in pa...
متن کاملFecal calprotectin is a good biomarker of mucosal healing in monitoring of children with IBD
Introduction. Fecal calprotectin (FC) concentrations of patients with inflammatory bowel diseases (IBD) are much higher than those of healthy controls or patients with functional disorders or other gastrointestinal diseases. Thus FC is a good biomarker of gut inflammation in differential diagnosis of IBD as well as mucosal healing in monitoring of IBD in adults. There is shortage of data concer...
متن کاملFecal Calprotectin Testing
INSTRUCTIONS FOR USE This Medical Policy provides assistance in interpreting UnitedHealthcare benefit plans. When deciding coverage, the enrollee specific document must be referenced. The terms of an enrollee's document (e.g., Certificate of Coverage (COC) or Summary Plan Description (SPD) and Medicaid State Contracts) may differ greatly from the standard benefit plans upon which this Medical P...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Canadian Association of Gastroenterology
سال: 2018
ISSN: 2515-2084,2515-2092
DOI: 10.1093/jcag/gwy009.151